Fujiyama S - Search Results

1

Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma.

Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, Fujiyama S, Tomita K. Ikeda M, et al. Among authors: fujiyama s. Oncology. 2004;66(1):24-31. doi: 10.1159/000076331. Oncology. 2004. PMID: 15031595 Clinical Trial.

2

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.

Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Fujiyama S, et al. Oncology. 2002;62 Suppl 1:57-63. doi: 10.1159/000048277. Oncology. 2002. PMID: 11868787 Review.

3

Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization.

Maeda S, Fujiyama S, Tanaka M, Ashihara H, Hirata R, Tomita K. Maeda S, et al. Among authors: fujiyama s. Hepatol Res. 2002 Jul;23(3):202-210. doi: 10.1016/s1386-6346(01)00174-7. Hepatol Res. 2002. PMID: 12076716

4

Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.

Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K. Maeda S, et al. Among authors: fujiyama s. Hepatogastroenterology. 2003 May-Jun;50(51):809-13. Hepatogastroenterology. 2003. PMID: 12828090

5

[Tumor markers for hepatocellular carcinoma].

Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R. Fujiyama S, et al. Gan To Kagaku Ryoho. 2001 May;28(5):723-32. Gan To Kagaku Ryoho. 2001. PMID: 11383225 Japanese.

6

Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol.

Fujiyama S, Shibata J, Maeda S, Tanaka M, Noumaru S, Sato K, Tomita K. Fujiyama S, et al. Br J Cancer. 2003 Nov 3;89(9):1614-9. doi: 10.1038/sj.bjc.6601318. Br J Cancer. 2003. PMID: 14583758 Free PMC article. Clinical Trial.

7

[Multidisciplinary treatment for hepatocellular carcinoma invading the stomach].

Takahashi M, Beppu T, Doi K, Ishiko T, Kai K, Doi Y, Okabe H, Egami H, Ashihara H, Fujiyama S, Ogawa M. Takahashi M, et al. Among authors: fujiyama s. Gan To Kagaku Ryoho. 2003 Oct;30(11):1741-4. Gan To Kagaku Ryoho. 2003. PMID: 14619508 Japanese.

8

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.

Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. Ikeda M, et al. Among authors: fujiyama s. J Gastroenterol. 2005 Feb;40(2):148-56. doi: 10.1007/s00535-004-1519-2. J Gastroenterol. 2005. PMID: 15770398

9

Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.

Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. Ikeda M, et al. Among authors: fujiyama s. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):122-8. doi: 10.1111/j.1440-1746.2005.04083.x. J Gastroenterol Hepatol. 2006. PMID: 16706823

10

[Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].

Fujiyama S, Morishita T, Shibata J, Sato T. Fujiyama S, et al. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1129-38. Gan To Kagaku Ryoho. 1989. PMID: 2471453 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters